Management of patients with arterial hypertension and atrial fibrillation
Arterial hypertension (AH) is a leading risk factor for cardiovascular disease as well as it is the most common, independent and potentially reversible risk factor for atrial fibrillation (AF). AH contributes to the occurrence and maintenance of AF due to hemodynamic disorders, alterations in cardio...
Guardado en:
Autores principales: | Irina E. Chazova, Sergei P. Golitsyn, Juliya V. Zhernakova, Ekaterina A. Zheleznova, Ekaterina S. Kropacheva, Nikolai Iu. Mironov, Marina V. Kostiukevich, Lada Iu. Laiovich, Madina D. Utsumueva, Iuliia A. Iuricheva, Alexander Yu. Litvin, Evgeniia M. Elfimova, Anatolii N. Rogoza, Elizaveta P. Panchenko |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Morozov P.V.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a62932e2890b4be5b090cec8bd168e61 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
por: Abdelmoniem Moustafa, et al.
Publicado: (2020) -
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
por: Abdelmoniem Moustafa, et al.
Publicado: (2019) -
Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
por: Yutao Guo, et al.
Publicado: (2010) -
Expert consensus. Effect of antihypertensive therapy on cognitive functions
por: Olga D. Ostroumova, et al.
Publicado: (2021) -
Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities
por: Arahata M, et al.
Publicado: (2018)